Xiaoping Wu

468 total citations
19 papers, 361 citations indexed

About

Xiaoping Wu is a scholar working on Cancer Research, Molecular Biology and Complementary and alternative medicine. According to data from OpenAlex, Xiaoping Wu has authored 19 papers receiving a total of 361 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Cancer Research, 12 papers in Molecular Biology and 3 papers in Complementary and alternative medicine. Recurrent topics in Xiaoping Wu's work include Cancer-related molecular mechanisms research (9 papers), MicroRNA in disease regulation (5 papers) and RNA modifications and cancer (5 papers). Xiaoping Wu is often cited by papers focused on Cancer-related molecular mechanisms research (9 papers), MicroRNA in disease regulation (5 papers) and RNA modifications and cancer (5 papers). Xiaoping Wu collaborates with scholars based in China, United Kingdom and Australia. Xiaoping Wu's co-authors include Zewei Luo, Fang Ou, Lindsey Leach, Hongbo Zhu, Yuehua Li, Xiaofei Qu, Ting Liu, Xiangxiang Hu, Yeru Tan and Yiling Jiang and has published in prestigious journals such as Applied Physics Letters, Advanced Functional Materials and Oncogene.

In The Last Decade

Xiaoping Wu

16 papers receiving 357 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaoping Wu China 10 271 255 46 33 32 19 361
Linqiang Li China 8 224 0.8× 168 0.7× 35 0.8× 40 1.2× 30 0.9× 17 311
Honglei Jin China 9 235 0.9× 151 0.6× 47 1.0× 26 0.8× 20 0.6× 11 282
Jiali Long China 8 306 1.1× 262 1.0× 34 0.7× 22 0.7× 25 0.8× 12 371
Huaixiang Zhou China 8 322 1.2× 239 0.9× 55 1.2× 16 0.5× 17 0.5× 12 380
Qiangnu Zhang China 12 277 1.0× 217 0.9× 50 1.1× 35 1.1× 65 2.0× 24 372
Mujie Ye China 16 400 1.5× 257 1.0× 81 1.8× 50 1.5× 39 1.2× 38 510
Siyuan Wu China 11 266 1.0× 212 0.8× 24 0.5× 21 0.6× 24 0.8× 24 321

Countries citing papers authored by Xiaoping Wu

Since Specialization
Citations

This map shows the geographic impact of Xiaoping Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoping Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoping Wu more than expected).

Fields of papers citing papers by Xiaoping Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoping Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoping Wu. The network helps show where Xiaoping Wu may publish in the future.

Co-authorship network of co-authors of Xiaoping Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaoping Wu. A scholar is included among the top collaborators of Xiaoping Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaoping Wu. Xiaoping Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Zhang, Xu, Ke Zhao, Liu Zhang, et al.. (2025). In situ Crosslinked Robust Molecular Zipper at the Buried Interface for Perovskite Photovoltaics. Advanced Functional Materials. 35(28). 9 indexed citations
2.
Hu, Haiyao, Huilin Li, Xiaoping Wu, et al.. (2025). Effective carrier management in perovskite solar cells via ferroelectric polarization. Applied Physics Letters. 126(17).
3.
Luo, Guohui, Penghui Ren, Linfeng Zhang, et al.. (2024). Multifunctional Regulation of Chemical Bath Deposition Based SnO 2 for Efficient Perovskite Solar Cells. Small. 21(3). e2406696–e2406696. 4 indexed citations
4.
Yan, Zijun, et al.. (2024). Nanoemulsion based lipid nanoparticles for effective demethylcantharidin delivery to cure liver cancer. Chemical Biology & Drug Design. 104(1). e14580–e14580. 2 indexed citations
5.
6.
7.
Yan, Zijun, Xiaoping Wu, Panpan Wei, et al.. (2023). Effective Platform for Enhancing the Bioavailability and Anti-Cancer Efficacy of Norcantharidin: Nanoemulsion Hybrid Lipid Carriers. Journal of Biomedical Nanotechnology. 19(4). 527–542.
8.
9.
Zhu, Hongbo, et al.. (2021). MALAT1 Promotes Tumorigenesis and Increases Cellular Sensitivity to Herceptin in HER2-positive Breast Cancer. Current Cancer Drug Targets. 21(10). 860–869. 8 indexed citations
10.
Zhu, Hongbo, Ting Gao, Zhou Yu, et al.. (2021). Apatinib Inhibits Stem Properties and Malignant Biological Behaviors of Breast Cancer Stem Cells by Blocking Wnt/β-catenin Signal Pathway through Downregulating LncRNA ROR. Anti-Cancer Agents in Medicinal Chemistry. 22(9). 1723–1734. 12 indexed citations
11.
Huang, Jiansheng, et al.. (2020). MicroRNA‑132‑3p regulates cell proliferation, apoptosis, migration and invasion of liver cancer by targeting Sox4. Oncology Letters. 19(4). 3173–3180. 13 indexed citations
12.
Li, Junyu, Yuehua Li, Xiaoping Wu, & Ying Li. (2019). Identification and validation of potential long non‑coding RNA biomarkers in predicting survival of patients with head and neck squamous cell carcinoma. Oncology Letters. 17(6). 5642–5652. 7 indexed citations
13.
Li, Yuehua, Xiaoping Wu, Wenqi Chen, et al.. (2018). Long non-coding RNA MIAT is estrogen-responsive and promotes estrogen-induced proliferation in ER-positive breast cancer cells. Biochemical and Biophysical Research Communications. 503(1). 45–50. 43 indexed citations
14.
Li, Yuehua, Xiaofei Qu, Hongbo Zhu, et al.. (2018). Long noncoding RNA cancer susceptibility candidate�9 promotes doxorubicin‑resistant breast cancer by binding to enhancer of zeste homolog 2. International Journal of Molecular Medicine. 42(5). 2801–2810. 31 indexed citations
15.
Xiang, Tianxin, et al.. (2017). Oxidored-nitro domain-containing protein 1 promotes liver fibrosis by activating the Wnt/β-catenin signaling pathway in vitro. Molecular Medicine Reports. 16(4). 5050–5054. 9 indexed citations
16.
Li, Yuehua, Hongbo Zhu, Xiaofei Qu, et al.. (2017). Inhibition of long non-coding RNA ROR reverses resistance to Tamoxifen by inducing autophagy in breast cancer. Tumor Biology. 39(6). 3726132179–3726132179. 64 indexed citations
17.
Han, Rong, et al.. (2015). Effect of total flavonoids from the seeds of Astragali complanati on natural killer cell function. Journal of Ethnopharmacology. 173. 157–165. 23 indexed citations
18.
Wu, Xiaoping, Tianchi Liu, Fang Ou, et al.. (2015). MicroRNA-708-5p acts as a therapeutic agent against metastatic lung cancer. Oncotarget. 7(3). 2417–2432. 47 indexed citations
19.
Wu, Xiaoping, Ting Liu, Fang Ou, et al.. (2013). miR-194 suppresses metastasis of non-small cell lung cancer through regulating expression of BMP1 and p27kip1. Oncogene. 33(12). 1506–1514. 85 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Linqiang Li Breakdown of academic impact, for papers by Honglei Jin Breakdown of academic impact, for papers by Jiali Long Breakdown of academic impact, for papers by Huaixiang Zhou Breakdown of academic impact, for papers by Qiangnu Zhang Breakdown of academic impact, for papers by Mujie Ye Breakdown of academic impact, for papers by Siyuan Wu
Rankless by CCL
2026